Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical Antipsychotics

NCT03730857 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

111

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Olanzapine
DRUG: risperidone
DRUG: Paliperidone

Sponsor

Calo Psychiatric Center